Innovative liposomal amphotericin B formulation for oral treatment of visceral leishmaniasis.

Morais HLO, Ramos GS, Vallejos VMR, Santos TT, da Silva PHR, Colangelo JF, Fujiwara RT, Teobaldo GBM, de Oliveira CLP, Fernandes C, Aguiar MMG, Frézard F

Open source

DOI: 10.1016/j.ijpharm.2026.127414
Published: 2026 Sep 18
Container: International journal of pharmaceutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127414,
  title = {Innovative liposomal amphotericin B formulation for oral treatment of visceral leishmaniasis.},
  author = {Morais HLO and Ramos GS and Vallejos VMR and Santos TT and da Silva PHR and Colangelo JF and Fujiwara RT and Teobaldo GBM and de Oliveira CLP and Fernandes C and Aguiar MMG and Frézard F},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127414},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127414}
}

RIS

TY  - JOUR
TI  - Innovative liposomal amphotericin B formulation for oral treatment of visceral leishmaniasis.
AU  - Morais HLO
AU  - Ramos GS
AU  - Vallejos VMR
AU  - Santos TT
AU  - da Silva PHR
AU  - Colangelo JF
AU  - Fujiwara RT
AU  - Teobaldo GBM
AU  - de Oliveira CLP
AU  - Fernandes C
AU  - Aguiar MMG
AU  - Frézard F
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127414
UR  - https://doi.org/10.1016/j.ijpharm.2026.127414
ER  -

APA

HLO, M., GS, R., VMR, V., TT, S., PHR, D. S., JF, C., RT, F., GBM, T., CLP, D. O., C, F., MMG, A., & F, F. (2026). Innovative liposomal amphotericin B formulation for oral treatment of visceral leishmaniasis.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127414

Source records

pubmed · retrieved 2026-09-26T13:39:15.442Z